Biovail Corp.

biovail corp. - All News and Analysis

• Biovail Corporation Q2 2008 Earnings Call Transcript

  Seeking Alpha - 2008-09-24

  Question-and-Answer Session Operator Thank you, sir; we will now take questions from the listeners. Operator Instructions The first question’s from Randall Stanicky - Goldman Sachs. Randall Stanicky - Goldman Sachs Great, thanks a lot for the question. Bill, just a question first on the uses of...

  Tags: Biovail Corp.

• Analysts Express Confidence in Biovail's New Strategy

  Seeking Alpha - 2008-09-18

  FP Trading Desk submits: Biovail Corp.'s BVF acquisition of Prestwick Pharmaceuticals on Wednesday may not have been well received by investors, but according to RBC Capital analyst Douglas Miehm, it is a move in the right direction for the pharmaceutical company in transition.  On Wednesday, Biovail said it bought...

  Tags: Biovail Corp., Biotech

• RBC Likes Biovail's Strategy Shift

  Seeking Alpha - 2008-08-14

  FP Trading Desk submits: RBC Capital Markets analyst Doug Miehm offered qualified support for drug maker Biovail Corp.'s BVF much talked about strategic shift into central nervous system drugs, praising management in a note this morning for doing "a good job" of explaining the new focus. However, in a...

  Tags: Biovail Corp., Healthcare

• New Analyst Reports for Q9 NETWORKS INC, GRIZZLY DIAMONDS LTD, BIOVAIL CORPORATION, and PARAMOUNT RESOURCES LTD

  - 2008-06-16

  MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments Q9 NETWORKS...

  Tags: analyst report, Biovail Corp., network

• Biovail Announces That RiskMetrics Group Recommends Shareholders Vote "For" Biovail's Director Nominees

  - 2008-06-14

  RiskMetrics Notes Current Board and Management "Are Well Versed in Taking the Tough Business Decisions That Will Allocate Resources in the Most Value Enhancing Areas"

  Tags: Biovail Corp., shareholder

• Biovail Provides Update on Share Repurchase Program

  - 2008-06-13

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that, as of June 12, 2008, the Company has purchased over 1,000,000 of its common shares under its previously announced share repurchase program. Open-market purchases continue under the program.

  Tags: Biovail Corp.

• Biovail to Present at 2008 Goldman Sachs Global Healthcare Conference

  - 2008-06-10

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX: BVF) today announced that the Company will present at the 2008 Goldman Sachs Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel in Dana Point, California.

  Tags: Biovail Corp., Goldman Sachs & Co., health care

• Biovail Shareholders Should Disregard the Latest Misinformation from Eugene Melnyk

  - 2008-06-09

  Vote Your BLUE Proxy Now

  Tags: Biovail Corp., shareholder

• Biovail Responds to Dissident Circular

  - 2008-06-06

  Vote Your BLUE Proxy Now

  Tags: Biovail Corp.

• Biovail Notes Filing of Dissident Circular

  - 2008-06-03

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) confirmed today that it has been advised of the filing of a dissident proxy circular by former Chairman and Chief Executive Officer CEO Eugene Melnyk, in which Mr. Melnyk proposes his own slate of nominees for election to the Board of Directors of Biovail.

  Tags: Biovail Corp.

• Biovail Launches Normal Course Issuer Bid

  - 2008-05-27

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that commencing on June 2, 2008 it may make purchases of its common shares on the open market under its previously announced normal course issuer bid NCIB.

  Tags: Biovail Corp.

• Bernstein Litowitz and Milberg LLP Announce the Proposed Settlement of a Securities Class Action Lawsuit against Biovail Corporation and Certain of Its Officers or Directors for U.S.$138 Million in Cash

  - 2008-05-16

  NEW YORK -- This Notice relates to the following actions:

  Tags: Biovail Corp.

• Biovail Announces Mailing and Filing of Management Proxy Circular

  - 2008-05-16

  Shareholders Urged to Complete the BLUE Form of Proxy in Favour of Biovail's Board Nominees

  Tags: Biovail Corp.

• Biovail Subsidiary Reaches Settlement with United States Department of Justice

  - 2008-05-16

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that a subsidiary of the Company has reached an agreement with the United States Department of Justice DOJ in respect of criminal allegations related to activities surrounding the 2003 commercial launch of Cardizem[R] LA. In particular, the allegations relate to prior management's actions...

  Tags: agreement, Biovail Corp., U.S. Department of Justice

• New Analyst Reports for NORTHSTAR HEALTHCARE INC, THOMPSON CREEK METALS COMPANY INC, BIOVAIL CORPORATION, and KATANGA MINING LTD

  - 2008-05-14

  MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments NORTHSTAR HEALTHCARE...

  Tags: analyst report, Biovail Corp.

• Biovail Reports First-Quarter 2008 Financial Results

  - 2008-05-08

  TORONTO -- Biovail Corporation (NYSE/TSX: BVF) today announced its financial results for the three-month period ended March 31, 2008.

  Tags: Biovail Corp.

• Biovail Announces New Strategic Focus

  - 2008-05-08

  Focus on High-Growth Central Nervous System Disorder Specialty Markets;

  Tags: Biovail Corp.

• Biovail Declares Quarterly Dividend

  - 2008-05-08

  TORONTO -- Biovail Corporation (NYSE: BVF) (TSX: BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.375 per share payable on May 30, 2008, to shareholders of record at the close of business May 22, 2008.

  Tags: Biovail Corp., dividend

• Biovail Announces Normal Course Issuer Bid

  - 2008-05-08

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that its Board of Directors has authorized a share repurchase program of up to 14,000,000 common shares, representing up to approximately 10% of its public float. As of the date hereof, Biovail has 161,023,729 common shares issued and outstanding. Biovail intends to begin...

  Tags: Biovail Corp.

• Biovail Receives FDA Approval for Aplenzin

  - 2008-04-23

  TORONTO -- Biovail Corporation (NYSE: BVF) (TSX: BVF) announced today that it has received Approval from the United States Food and Drug Administration FDA for its New Drug Application NDA for Aplenzin[TM] (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression...

  Tags: Biovail Corp.